Caravans of Americans are heading to Canada for cheaper insulin
Lija Greenseid, "a rule-abiding Minnesota mom," just led a small caravan of Americas to Canada to buy analog insulin for her 13-year-old daughter, and "she and five other Americans paid about $1,200 for drugs that would have cost them $12,000 in the United States," The Washington Post reports. As other people dealing with Type 1 diabetes and the rapidly rising price of insulin hear about her journeys north of the border, the caravan is growing — the next one will be on a chartered bus.
These drug runs to Canada — where you can buy analog insulin without a prescription, unlike in the U.S. — may be illegal. "But the organizers of the caravan — their word, a nod to the migrants traveling in groups through Mexico to the U.S. border — are speaking out about their trip because they want Americans to see how drug prices push ordinary people to extremes," the Post reports.
Canadians get the caravan reference, too. While many of them were supportive of the American caravan, others expressed concern about the supplies of Canadian insulin. "We heard a lot of comments like, 'Canada needs to put up a wall,'" said caravaner Nicole Smith-Holt. "I was like, 'Oh, come on.'"
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The Pharmaceutical Research and Manufacturers of America (PhRMA) lobbying group blamed insurance companies for the cost of insulin, which doubled in the U.S. between 2012 and 2016, saying drug companies are increasingly offering rebates on insulin that aren't reaching patients.
Barry Power, the Canadian Pharmacists Association's director of therapeutic content, told the Post that the caravans and other cross-border drug purchasers haven't yet affected Canada's insulin supply. Canada keeps insulin prices low through a combination of price caps, negotiations with drug manufactures, and other policy, he added. "This is something the U.S. could do." Learn more at The Washington Post, or in the New York Times video op-ed below. Peter Weber
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Reddit IPO values social media site at $6.4 billion
Speed Read The company makes its public debut on the New York Stock Exchange
By Peter Weber, The Week US Published
-
Housing costs: the root of US economic malaise?
speed read Many voters are troubled by the housing affordability crisis
By Peter Weber, The Week US Published
-
Feds cap credit card late fees at $8
speed read The Consumer Financial Protection Bureau finalized a rule to save households an estimated $10 billion a year
By Peter Weber, The Week US Published
-
Immigration helped the US economy outpace peers
speed read The U.S. economy grew at an annualized rate of 3.2% last quarter
By Peter Weber, The Week US Published
-
4-day workweek gets boost from UK study
Speed Read Following a six-month trial, the majority of participating British companies are still using the truncated schedule
By Peter Weber, The Week US Published
-
US sues to block Kroger-Albertsons merger
Speed Read The Federal Trade Commission sued to block the $24.6 billion merger between the grocery giants
By Peter Weber, The Week US Published
-
Nvidia sees historic stock rise on AI chips success
Speed Read U.S. chipmaker Nvidia achieved the biggest one-day increase in value of any company in history
By Peter Weber, The Week US Published
-
New York may seize Trump's assets for $450M penalty
Speed Read The former president likely owes $600 million from two civil judgments in New York
By Peter Weber, The Week US Published